[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fcnIvWME57j2gWteShA886x9Iv-xLCMiEII4U3hYWyi4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"Universität Duisburg-Essen",[4],82,false,12,3,8826,0,73,[14,17,20,23,25,27,29,32],{"name":15,"count":16},"Neck Pain",8,{"name":18,"count":19},"Irritable Bowel Syndrome",6,{"name":21,"count":22},"Breast Cancer",4,{"name":24,"count":22},"Chronic Pain",{"name":26,"count":9},"Migraine",{"name":28,"count":9},"Ulcerative Colitis",{"name":30,"count":31},"Depression, Unipolar",2,{"name":33,"count":31},"Mechanical\u002FMotor Problems With Neck and Trunk",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,69,95,133,151,169,204,228,252,270,295],{"intervention":44,"totalTrials":45,"cells":46},"Rizatriptan",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":55,"NA":67},{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[],{"trials":56,"activeCount":11},[57],{"nctId":58,"briefTitle":59,"status":60,"phases":61,"primaryCompletion":62,"completion":62,"start":63,"enrollment":64,"conditions":65,"interventions":66},"NCT01057160","Rizatriptan 10 MG RPD in the Treatment of Acute Migraine","COMPLETED",[40],"2010-06","2008-05",195,[26],[44],{"trials":68,"activeCount":11},[],{"intervention":70,"totalTrials":45,"cells":71},"Individualized internal ayurvedic treatment",{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":91,"NA":93},{"trials":73,"activeCount":11},[],{"trials":75,"activeCount":11},[],{"trials":77,"activeCount":11},[],{"trials":79,"activeCount":11},[80],{"nctId":81,"briefTitle":82,"status":60,"phases":83,"primaryCompletion":84,"completion":85,"start":86,"enrollment":87,"conditions":88,"interventions":90},"NCT04146558","Ayurvedic Treatment Package in Plaque Psoriasis",[39],"2023-06-30","2023-12-31","2019-12-04",90,[89],"Psoriasis",[70],{"trials":92,"activeCount":11},[],{"trials":94,"activeCount":11},[],{"intervention":96,"totalTrials":31,"cells":97},"Pemetrexed",{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":127,"PHASE4":129,"NA":131},{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[104,115],{"nctId":105,"briefTitle":106,"status":107,"phases":108,"primaryCompletion":109,"completion":109,"start":110,"enrollment":22,"conditions":111,"interventions":113},"NCT02595840","Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE)","TERMINATED",[38],"2017-11-20","2015-11-25",[112],"Non-small-cell Lung Cancer With Somatic EGFR Mutations",[114,96],"Afatinib",{"nctId":116,"briefTitle":117,"status":118,"phases":119,"primaryCompletion":120,"completion":121,"start":122,"conditions":123,"interventions":125},"NCT01742767","Cisplatinum\u002FPemetrexed Versus Split-dose Cisplatinum\u002FPemetrexed In NSCLC","UNKNOWN",[38],"2014-05","2015-04","2012-11",[124],"NSCLC",[126,96],"Cisplatinum",{"trials":128,"activeCount":11},[],{"trials":130,"activeCount":11},[],{"trials":132,"activeCount":11},[],{"intervention":114,"totalTrials":45,"cells":134},{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":145,"PHASE4":147,"NA":149},{"trials":136,"activeCount":11},[],{"trials":138,"activeCount":11},[],{"trials":140,"activeCount":11},[141],{"nctId":105,"briefTitle":106,"status":107,"phases":142,"primaryCompletion":109,"completion":109,"start":110,"enrollment":22,"conditions":143,"interventions":144},[38],[112],[114,96],{"trials":146,"activeCount":11},[],{"trials":148,"activeCount":11},[],{"trials":150,"activeCount":11},[],{"intervention":126,"totalTrials":45,"cells":152},{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":163,"PHASE4":165,"NA":167},{"trials":154,"activeCount":11},[],{"trials":156,"activeCount":11},[],{"trials":158,"activeCount":11},[159],{"nctId":116,"briefTitle":117,"status":118,"phases":160,"primaryCompletion":120,"completion":121,"start":122,"conditions":161,"interventions":162},[38],[124],[126,96],{"trials":164,"activeCount":11},[],{"trials":166,"activeCount":11},[],{"trials":168,"activeCount":11},[],{"intervention":170,"totalTrials":31,"cells":171},"Diclofenac Gel",{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":178,"PHASE4":180,"NA":182},{"trials":173,"activeCount":11},[],{"trials":175,"activeCount":11},[],{"trials":177,"activeCount":11},[],{"trials":179,"activeCount":11},[],{"trials":181,"activeCount":11},[],{"trials":183,"activeCount":11},[184,195],{"nctId":185,"briefTitle":186,"status":60,"phases":187,"primaryCompletion":188,"completion":189,"start":190,"enrollment":191,"conditions":192,"interventions":194},"NCT03528824","Fenugreek Wraps in Osteoarthritis of the Knee",[41],"2020-08-01","2020-09-01","2018-06-01",81,[193],"Osteoarthritis, Knee",[170],{"nctId":196,"briefTitle":197,"status":60,"phases":198,"primaryCompletion":199,"completion":199,"start":200,"enrollment":191,"conditions":201,"interventions":203},"NCT02027792","Cabbage Leaf Wraps in Osteoarthritis of the Knee",[41],"2014-08","2014-01",[202],"Osteoarthritis of the Knee",[170],{"intervention":205,"totalTrials":45,"cells":206},"Ayurvedic Herbs",{"EARLY_PHASE1":207,"PHASE1":209,"PHASE2":211,"PHASE3":213,"PHASE4":215,"NA":217},{"trials":208,"activeCount":11},[],{"trials":210,"activeCount":11},[],{"trials":212,"activeCount":11},[],{"trials":214,"activeCount":11},[],{"trials":216,"activeCount":11},[],{"trials":218,"activeCount":11},[219],{"nctId":220,"briefTitle":221,"status":60,"phases":222,"primaryCompletion":223,"completion":223,"start":224,"enrollment":225,"conditions":226,"interventions":227},"NCT01418066","Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome",[41],"2012-12","2011-08",32,[18],[205],{"intervention":229,"totalTrials":45,"cells":230},"caraway oil",{"EARLY_PHASE1":231,"PHASE1":233,"PHASE2":235,"PHASE3":237,"PHASE4":239,"NA":241},{"trials":232,"activeCount":11},[],{"trials":234,"activeCount":11},[],{"trials":236,"activeCount":11},[],{"trials":238,"activeCount":11},[],{"trials":240,"activeCount":11},[],{"trials":242,"activeCount":11},[243],{"nctId":244,"briefTitle":245,"status":60,"phases":246,"primaryCompletion":247,"completion":247,"start":224,"enrollment":248,"conditions":249,"interventions":250},"NCT01418053","The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome",[41],"2013-09",48,[18],[229,251],"Olive oil",{"intervention":251,"totalTrials":45,"cells":253},{"EARLY_PHASE1":254,"PHASE1":256,"PHASE2":258,"PHASE3":260,"PHASE4":262,"NA":264},{"trials":255,"activeCount":11},[],{"trials":257,"activeCount":11},[],{"trials":259,"activeCount":11},[],{"trials":261,"activeCount":11},[],{"trials":263,"activeCount":11},[],{"trials":265,"activeCount":11},[266],{"nctId":244,"briefTitle":245,"status":60,"phases":267,"primaryCompletion":247,"completion":247,"start":224,"enrollment":248,"conditions":268,"interventions":269},[41],[18],[229,251],{"intervention":271,"totalTrials":45,"cells":272},"Whole-body hyperthermia + standard medical care",{"EARLY_PHASE1":273,"PHASE1":275,"PHASE2":277,"PHASE3":279,"PHASE4":281,"NA":283},{"trials":274,"activeCount":11},[],{"trials":276,"activeCount":11},[],{"trials":278,"activeCount":11},[],{"trials":280,"activeCount":11},[],{"trials":282,"activeCount":11},[],{"trials":284,"activeCount":11},[285],{"nctId":286,"briefTitle":287,"status":60,"phases":288,"primaryCompletion":289,"completion":289,"start":290,"enrollment":291,"conditions":292,"interventions":293},"NCT03906149","Whole-body Hyperthermia for Moderate to Severe Depressive Disorder",[41],"2023-01-20","2019-07-01",46,[30],[271,294],"Standard medical care",{"intervention":294,"totalTrials":45,"cells":296},{"EARLY_PHASE1":297,"PHASE1":299,"PHASE2":301,"PHASE3":303,"PHASE4":305,"NA":307},{"trials":298,"activeCount":11},[],{"trials":300,"activeCount":11},[],{"trials":302,"activeCount":11},[],{"trials":304,"activeCount":11},[],{"trials":306,"activeCount":11},[],{"trials":308,"activeCount":11},[309],{"nctId":286,"briefTitle":287,"status":60,"phases":310,"primaryCompletion":289,"completion":289,"start":290,"enrollment":291,"conditions":311,"interventions":312},[41],[30],[271,294]]